CHEBI:83807 - paliperidone palmitate

ChEBI IDCHEBI:83807
ChEBI Namepaliperidone palmitate
Stars
DefinitionA racemate comprising equimolar amounts of (R)- and (S)-paliperidone palmitate. A long-acting injectable formulation of paliperidone (the major active metabolite of risperidone) that is used for treatment of schizophrenia.
Last Modified22 February 2017
SubmitterSteve
FormulaC39H57FN4O4
Net Charge0
Average Mass664.893
Monoisotopic Mass664.43638
Wikipedia
Roles Classification
Biological Roles:
dopaminergic antagonist  A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
alpha-adrenergic antagonist  An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
H1-receptor antagonist  H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
serotonergic antagonist  Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
Applications:
dopaminergic antagonist  A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
psychotropic drug  A loosely defined grouping of drugs that have effects on psychological function.
neuroprotective agent  Any compound that can be used for the treatment of neurodegenerative disorders.
alpha-adrenergic antagonist  An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
second generation antipsychotic  Antipsychotic drugs which can have different modes of action but which tend to be less likely than first generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson's disease-type movements.
H1-receptor antagonist  H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
serotonergic antagonist  Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
ChEBI Ontology
Outgoing Relation(s)
paliperidone palmitate (CHEBI:83807) has part (R)-paliperidone palmitate (CHEBI:83810)
paliperidone palmitate (CHEBI:83807) has part (S)-paliperidone palmitate (CHEBI:83809)
paliperidone palmitate (CHEBI:83807) has role dopaminergic antagonist (CHEBI:48561)
paliperidone palmitate (CHEBI:83807) has role H1-receptor antagonist (CHEBI:37955)
paliperidone palmitate (CHEBI:83807) has role neuroprotective agent (CHEBI:63726)
paliperidone palmitate (CHEBI:83807) has role psychotropic drug (CHEBI:35471)
paliperidone palmitate (CHEBI:83807) has role second generation antipsychotic (CHEBI:65191)
paliperidone palmitate (CHEBI:83807) has role serotonergic antagonist (CHEBI:48279)
paliperidone palmitate (CHEBI:83807) has role α-adrenergic antagonist (CHEBI:37890)
paliperidone palmitate (CHEBI:83807) is a racemate (CHEBI:60911)
IUPAC Name 
rac-3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-9-yl hexadecanoate
Synonyms  Source
RO92670ChemIDplus
RO 92670ChemIDplus
paliperidone hexadecanoateChEBI
(RS)-paliperidone palmitateChEBI
(±)-paliperidone palmitateChEBI
rac-paliperidone palmitateChEBI
Brand Names  Source
INVEGA SUSTENNAKEGG DRUG
XeplionKEGG DRUG
Manual XrefsDatabases
D05340KEGG DRUG
PaliperidoneWikipedia
Registry NumbersSources
Reaxys:15026585Reaxys
CAS:199739-10-1KEGG DRUG
CAS:199739-10-1ChemIDplus
Citations